Evidence map›Paper›PMID 29299161›Full record

ArticleOncotarget2017

Wenwen Yu, Yi Zheng, Zhujun Yang, Hongbo Fei, Yang Wang, Xu Hou, Xinhua Sun, Yuqin Shen

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Drug design, development and therapy · 2020
    Article
  8. Delivery of therapeutic miRNA using polymer-based formulation.Drug delivery and translational research · 2019
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wenwen YuDepartment of Orthodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Yi ZhengDepartment of Periodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Zhujun YangDepartment of Orthodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Hongbo FeiDepartment of Periodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Yang WangDepartment of Orthodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Xu HouDepartment of Orthodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Xinhua SunDepartment of Orthodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Yuqin ShenDepartment of Periodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare therapeutic genes or agents are reported to control orthodontic bone remodeling. MicroRNAs have recently been associated with bone metabolism. Here, we report the

Indexed as

miR-34aN-acetyl-L-leucine-polyethylenimineorthodontic tooth movementosteogenic differentiationstrain

Identifiers

PMID29299161
PMCPMC5746396
OpenAlexW2772371896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.